Prevalence of Renal Artery Stenosis in Patients Referred for Cardiac Catheterization
RAS
1 other identifier
observational
146
1 country
1
Brief Summary
All patients referred for coronary angiography will simultaneously be evaluated for renal artery stenosis and then stenosis more than 50% will be analyzed according to clinical conditions, risk factors and lab data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedFirst Posted
Study publicly available on registry
April 22, 2009
CompletedResults Posted
Study results publicly available
March 23, 2010
CompletedMay 13, 2011
April 1, 2009
2 months
July 11, 2008
March 9, 2010
May 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prevalence of Renal Artery Stenosis (RAS)
2 months
The Number of Patients With Renal Artery Stenosis
the prevalence of renal artery stenosis in patients with coronary artery disease
3months
Study Arms (1)
A
patients with renal artery stenosis
Interventions
all patients undergoing coronary angiography with VISIPAQUE and if they had coronary stenosis then renal artery angiography will be done. the dose of contrast will be chosen according to renal function and clinical conditions which will be varied from 75 to 300 ml.
Eligibility Criteria
All patients reffered to the Tehran Heart center for coronary angiography
You may qualify if:
- age more than 18 years
You may not qualify if:
- contraindication to contrast use
- not signing consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Imam Khomeini Hospitallead
- Tehran Heart Centercollaborator
Study Sites (1)
Tehran Heart Center
Tehran, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Mohammad Reza Khatami MD
- Organization
- Kidney Reasearch Center, Tehran University of Medical Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 11, 2008
First Posted
April 22, 2009
Study Start
July 1, 2008
Primary Completion
September 1, 2008
Study Completion
April 1, 2009
Last Updated
May 13, 2011
Results First Posted
March 23, 2010
Record last verified: 2009-04